Skip to main content
Clinical Trials/CTRI/2024/06/069492
CTRI/2024/06/069492
Not Yet Recruiting
Phase 2

A Pilot clinical study to explore the effectiveness of selected siddha drugs for Vathakarsanam(Diabetic Peripheral Neuropathy) through MNSI (score and questionnaire ) at Ayothidoss Pandithar Hospital , NIS - Nil

I0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Sponsor
I
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • NIDDN(Non Insulin Dependent Diabetic Medication) Glycated Hemoglobin 7% TO 10%
  • Michigan Neuropathy Screening Instrument (MNSI)\-Examination Score 2\.5/5 and MNSI Questionnaire Score 7/15 Consider Positive for the presence of Neuropathy
  • Known Diabetes Participants Already on OHAs With or without medication for more than 5 years with Numbness,Burning sensation of foot and Pricking Pain in both Leg and Foot and toes.

Exclusion Criteria

  • IDDM(Insulin Dependent Diabetes Mellitus)
  • Secondary Uncontrolled Hypertension (150 TO 90 MM HG)
  • Vitamin B12 Deficiency
  • CVA,Old CVA,Seizure disorder
  • Gestational Diabetes Mellitus
  • CKA and AKD Participants
  • Varicose Veins, Non Healing Ulcers,Amputation/Surgery in Lower Limb
  • Participans with lumbosacral radiculopathy testing Positive for Straight Leg Raising and Las Segue Sign

Outcomes

Primary Outcomes

Not specified

Similar Trials